Bone mineral density and trabecular bone score in treatment-naïve patients with non-cirrhotic hepatitis C virus infection
- 12 May 2020
- journal article
- research article
- Published by Springer Nature in Archives of Osteoporosis
- Vol. 15 (1) , 1-10
Abstract
Summary We studied 112 treatment-naïve chronic HCV patients without cirrhosis, and we found that, especially HCV+ postmenopausal women, they had lower TBS and BMD values than healthy controls. This suggests that HCV infection is an independent risk factor for osteoporosis, and therefore, screening for osteoporosis in postmenopausal HCV+ women should be considered. Purpose To know whether patients in earlier stages of chronic HCV infection are at increased risk of developing low bone mass and bone microarchitectural changes and whether there is an association between bone metabolism and the severity of the liver disease. Methods We studied 112 treatment-naïve chronic HCV outpatients and 233 healthy age- and sex-matched controls. Bone mineral density (BMD) and trabecular bone score (TBS) were assessed by DXA. Serum 25(OH)D, PTH, P1NP, and CTX were determined by electrochemiluminescence. Results TBS values were significantly lower in HCV patients than in controls, both considering the population as a whole (1.337 ± 0.119 vs. 1.377 ± 0.122; p < 0.005) and after stratifying by sex (1.347 ± 0.12 vs. 1.381 ± 0.13 in men and 1.314 ± 0.10 vs. 1.369 ± 0.11 in women). The difference remained significant (p < 0.0001 in all cases) after adjusting for confounders. BMD was also lower in HCV patients (lumbar spine, 0.935 ± 0.151 vs. 0.991 ± 0.143 g/cm2, p 0.001; femoral neck, 0.764 ± 0.123 vs. 0.818 ± 0.123 g/cm2, p 0.0001; total hip, 0.926 ± 0.148 vs. 0.963 ± 0.132 g/cm2, p 0.02), although, after adjustment, differences kept a clear trend towards statistical significance in women at the lumbar spine and femoral neck. However, in men and at the total hip in women, differences were no longer significant. We find no relationship between these parameters and the severity of the disease. No significant difference was observed in PTH and 25OHD status after adjustment. Finally, serum P1NP, but not CTX, was higher in HCV patients. Conclusions Our findings suggest that HCV infection is an independent risk factor for osteoporosis, especially among postmenopausal women. Therefore, the appropriateness of screening for osteoporosis in postmenopausal HCV-positive women should be considered.Keywords
This publication has 33 references indexed in Scilit:
- Hepatitis C Co-infection and Severity of Liver Disease as Risk Factors for Osteoporotic Fractures Among HIV-Infected PatientsJournal of Bone and Mineral Research, 2013
- Association Between Chronic Hepatitis C Virus Infection and Bone Mineral DensityCalcified Tissue International, 2012
- Osteoporosis en la cirrosis hepáticaGastroenterología y Hepatología, 2012
- Bone turnover markers in Spanish postmenopausal womenClinica Chimica Acta, 2009
- Bone mineral density and disorders of mineral metabolism in chronic liver diseaseWorld Journal of Gastroenterology, 2009
- Isoform of Fibronectin Mediates Bone Loss in Patients With Primary Biliary Cirrhosis by Suppressing Bone FormationJournal of Bone and Mineral Research, 2008
- The RANKL/OPG system and bone mineral density in patients with chronic liver diseaseJournal of Hepatology, 2005
- RANK Signaling Is Not Required for TNFα-Mediated Increase in CD11bhi Osteoclast Precursors but Is Essential for Mature Osteoclast Formation in TNFα-Mediated Inflammatory ArthritisJournal of Bone and Mineral Research, 2004
- Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice.Journal of Clinical Investigation, 1995
- Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO reportOsteoporosis International, 1994